Trichuris suis ova: Completed Phase II enrollment

Coronado completed enrollment of 250 patients in the double-blind, placebo-controlled, U.S. Phase II TRUST-I trial evaluating 7,500 T. suis ova every 2 weeks for 12 weeks. The trial includes a 12-week...